XML 75 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Contingent Consideration - Narrative (Details)
$ in Thousands
12 Months Ended
Nov. 24, 2021
USD ($)
right
Jun. 09, 2020
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Business Acquisition [Line Items]          
Fair value of contingent consideration   $ 230,000      
Payment of contingent consideration     $ 22,900 $ 0 $ 0
Fair value of excess of the acquisition     2,100    
Contingent consideration (gain) expense     (510) (6,530) $ 1,900
USWM Enterprises          
Business Acquisition [Line Items]          
Contingent consideration (gain) expense     (1,100) $ (6,500)  
Adamas Pharmaceuticals          
Business Acquisition [Line Items]          
Fair value of contingent consideration $ 10,307        
Contingent consideration (gain) expense     $ 1,600    
Contingents value rights | right 2        
SPN-830 Regulatory and Commercial Activities          
Business Acquisition [Line Items]          
Fair value of contingent consideration   130,000      
SPN-830 FDA Acceptance Milestone          
Business Acquisition [Line Items]          
Fair value of contingent consideration   55,000      
SPN-830 NDA Approval Milestone, Time-Based          
Business Acquisition [Line Items]          
Fair value of contingent consideration   50,000      
SPN-830 NDA Approval Milestone, Approval-Based          
Business Acquisition [Line Items]          
Fair value of contingent consideration   25,000      
SPN-830 NDA Approval Milestone          
Business Acquisition [Line Items]          
Fair value of contingent consideration   25,000      
SPN-830 Sale Milestone          
Business Acquisition [Line Items]          
Fair value of contingent consideration   100,000      
APOKYN          
Business Acquisition [Line Items]          
Fair value of contingent consideration   70,000      
APOKYN and SPN-830          
Business Acquisition [Line Items]          
Fair value of contingent consideration   30,000      
Subsequent Commercial Product Launch          
Business Acquisition [Line Items]          
Fair value of contingent consideration   $ 30,000